Company Filing History:
Years Active: 2024-2025
Title: Innovations by Shu-Ying Cheng in Cancer Treatment
Introduction
Shu-Ying Cheng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative approaches and patented methods. With a focus on developing effective therapies, Cheng has garnered attention for his work in pharmaceutical compositions.
Latest Patents
Cheng holds 2 patents that showcase his expertise in treating proliferative diseases. His latest patents include a method for treating cancer through a combination therapy. This therapy involves administering a pharmaceutical composition that includes a benzenesulfonamide derivative, such as p-Toluenesulfonamide, along with at least one other therapeutic agent from a different classification of anticancer agents. Additionally, he has developed methods for treating mast cell tumors, which involve a pharmaceutical composition that includes a benzenesulfonamide derivative and a pharmaceutically acceptable carrier.
Career Highlights
Cheng is associated with Gongwin Biopharm Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, and he is recognized for his innovative contributions to the pharmaceutical industry.
Collaborations
Cheng collaborates with esteemed colleagues, including Chuan-Ching Yang and Mao-Yuan Lin, to further enhance the impact of his research. Their combined efforts contribute to the development of effective cancer therapies.
Conclusion
Shu-Ying Cheng's innovative work in cancer treatment exemplifies the potential of pharmaceutical advancements. His patents reflect a commitment to improving patient outcomes through effective therapies.